Increased risk of reoperation and failure to attain clinically relevant improvement following autologous chondrocyte implantation of the knee in female patients and individuals with previous surgeries: a time‐to‐event analysis based on the German cartilage registry (KnorpelRegister DGOU)
Open Access
- 11 November 2023
- journal article
- research article
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 31 (12) , 5837-5847
Abstract
Purpose: This study aimed to analyze the risk of reoperation following autologous chondrocyte implantation (ACI) of the knee utilizing third‐generation ACI products in a time‐to‐event analysis and report on the associated patient‐reported outcome measures (PROM) in case of reoperation.Methods: Patients undergoing ACI were included from a longitudinal database. Patient age, sex, body mass index (BMI), number of previous surgeries, lesion localization, lesion size, symptom duration, as well as time and type of reoperation was extracted. A cox proportional‐hazards model was applied to investigate the influence of baseline variables on risk of reoperation. Reoperation was defined as any type of subsequent ipsilateral knee surgery, excluding hardware removal. The Knee Injury and Osteoarthritis Outcome Score (KOOS) was utilized to compare PROM between patients with and without reoperation.Results: A total of 2039 patients were included with 1359 (66.7%) having a minimum follow‐up of 24 months. There were overall 243 reoperations (prevalence 17.9%). Minor arthroscopic procedures (n = 96, 39.5%) and revision cartilage repair procedures (n = 78, 32.1%) were the most common reoperations. Nineteen patients (0.9%) reported conversion arthroplasty at 17.7 (10.4) months after ACI. Female sex (HR 1.5, 95% CI [1.2, 2.0], p = 0.002) and the presence of 1–2 previous surgeries (HR 1.5, 95% CI [1.1, 2.0], p = 0.010), or more than 2 previous surgeries (HR 1.9, 95% CI [1.2, 2.9], p = 0.004) were significantly associated with increased risk of reoperation following ACI. Significantly less patients surpassed the minimal clinically important difference (MCID) in the reoperation group at 24 months regarding the KOOS subscores pain (OR 1.6, 95% CI [1.1, 2.2]), quality of life (OR 2.2, 95% CI [1.6, 3.2]), symptoms (OR 2.0 [1.4, 2.9]), and sports (OR 2.0 [1.4, 2.8]).Conclusion: Female patients and individuals with a history of previous surgeries face an elevated risk of requiring reoperation after undergoing ACI, which is associated with failure to attain clinically relevant improvements. A thorough evaluation of the indications for ACI is paramount, particularly when patients have a history of previous surgeries.Level of evidence: Level III.Keywords
Funding Information
- Medizinische Universität Wien
- Medizinische Universität Wien
This publication has 26 references indexed in Scilit:
- Failures and Reoperations After Matrix‐Assisted Cartilage Repair of the Knee: A Systematic ReviewArthroscopy, 2015
- Revision surgery after third generation autologous chondrocyte implantation in the kneeInternational Orthopaedics, 2015
- Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus MicrofractureThe American Journal of Sports Medicine, 2014
- Does Patient Sex Influence Cartilage Surgery Outcome?The American Journal of Sports Medicine, 2013
- Is gender influencing the biomechanical results after autologous chondrocyte implantation?Knee Surgery, Sports Traumatology, Arthroscopy, 2012
- Minimum ten-year results of a prospective randomised study of autologous chondrocyte implantationversusmosaicplasty for symptomatic articular cartilage lesions of the kneeThe Journal of Bone and Joint Surgery. British volume, 2012
- Autologous Chondrocyte Implantation for Treatment of Cartilage Defects of the KneeThe American Journal of Sports Medicine, 2011
- Failures, re-operations, and complications after autologous chondrocyte implantation – a systematic reviewOsteoarthritis and Cartilage, 2011
- Characterized Chondrocyte Implantation Results in Better Structural Repair when Treating Symptomatic Cartilage Defects of the Knee in a Randomized Controlled Trial versus MicrofractureThe American Journal of Sports Medicine, 2008
- Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte TransplantationNew England Journal of Medicine, 1994